Business Context and Reporting Period
This Form 8-K filing by Runway Growth Finance Corp. (RWAY) covers the date of July 31, 2023. The report addresses significant changes in executive leadership and board composition due to the temporary medical leave of the Company's President, Chief Executive Officer, and Chairman.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance data.
Material Changes
- Executive Departure: R. David Spreng, President, CEO, and Chairman, is taking a temporary leave of absence for medical treatment effective July 31, 2023.
- Acting CEO Appointment: Greg Greifeld, Managing Director and Deputy Chief Investment Officer at Runway Growth Credit, LLC (the investment adviser), was appointed Acting Chief Executive Officer.
- Acting President Appointment: Thomas B. Raterman, previously CFO, Treasurer, Secretary, and COO, was appointed Acting President.
- Board Leadership Change: Julie Persily, an independent director and Chair of the Audit Committee, was appointed Acting Chairperson of the Board and Lead Independent Director.
Outlook, Risks, and Management Commentary
The appointments were executed in accordance with a succession plan approved by the Compensation Committee on April 6, 2023. The acting officers will serve until Mr. Spreng returns, successors are elected, or until resignation or removal. The filing explicitly states there are no undisclosed arrangements or family relationships regarding Mr. Greifeld's appointment, nor are there any transactions requiring disclosure under Item 404(a) of Regulation S-K. No specific financial risks or contingencies were detailed in this document.
Investor Verification Checklist
- Verify the expected duration of R. David Spreng's medical leave and the timeline for his return.
- Confirm the stability of the investment portfolio under the interim leadership of Greg Greifeld and Thomas B. Raterman.
- Review the Company's succession plan details approved in April 2023 for further governance context.
- Monitor subsequent filings for any updates on Mr. Spreng's status or permanent leadership changes.